Related references
Note: Only part of the references are listed.Antifungal Application of Nonantifungal Drugs
Marios Stylianou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
High-Throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors
Samuel A. Siles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Michael A. Pfaller
AMERICAN JOURNAL OF MEDICINE (2012)
The effect of biomaterials and antifungals on biofilm formation by Candida species: a review
M. Cuellar-Cruz et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Cytochrome P450-and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency
M. Stiborova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
The NF kappa B Pathway Inhibitors Bay 11-7082 and Parthenolide Induce Programmed Cell Death in Anucleated Erythrocytes
Mehrdad Ghashghaeinia et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)
Michael A. Pfaller et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms
Michael D. LaFleur et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
The pharmacological NFκB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation
Alfeu Zanotto-Filho et al.
CANCER LETTERS (2010)
Antitumor Activity of Pyridocarbazole and Benzopyridoindole Derivatives that Inhibit Protein Kinase CK2
Renaud Prudent et al.
CANCER RESEARCH (2010)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole
Rajendra J. Kothavade et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections
Ingi Lee et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts
Hiroshi Egusa et al.
BIOMATERIALS (2009)
Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans
T. Watamoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death
Seung-Joo Lee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion
Byeong-Churl Jang et al.
TOXICOLOGY IN VITRO (2009)
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms
C. J. Seneviratne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Eryptosis, a Window to Systemic Disease
Florian Lang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines
Smita S. Matkar et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
New options for treatment of candidaemia in critically ill patients
M. Ruhnke et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Development of a cell death-based method for the screening of nuclear factor-κB inhibitors
Puneet Chopra et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Antioxidant status of erythrocytes and their response to oxidative challenge in humans with argemone oil poisoning
Challagundla K. Babu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Conventional protein kinase C isoenzymes undergo dephosphorylation in neutrophil-like HL-60 cells treated by chelerythrine or sanguinarine
J. Vrba et al.
CELL BIOLOGY AND TOXICOLOGY (2008)
Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold bioniaterials
Yoshinosuke Hamada et al.
DENTAL MATERIALS JOURNAL (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Candida biofilms on implanted biomaterials:: a clinically significant problem
Gordon Ramage et al.
FEMS YEAST RESEARCH (2006)
Candida albicans biofilms produce antifungal-tolerant persister cells
Michael D. LaFleur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Developments in the treatment of candidiasis: more choices and new challenges
George Aperis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
An in vitro evaluation of the adhesion of Candida species to oral and lung tissue cells
H Nikawa et al.
MYCOSES (2006)
Currently used antimycotics:: Spectrum, mode of action and resistance occurrence
IEJA François et al.
CURRENT DRUG TARGETS (2005)
Changing patterns and trends in systemic fungal infections
MD Richardson
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
The benzo[c] phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1
A Vogt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interferon-gamma-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: Exploration of pharmaco- and gene-therapeutic effects
R Bockelmanna et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2005)
Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars
Y Jin et al.
ARCHIVES OF ORAL BIOLOGY (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Resistance of Candida species to antifungal agents:: molecular mechanisms and clinical consequences
D Sanglard et al.
LANCET INFECTIOUS DISEASES (2002)
Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance
J Chandra et al.
JOURNAL OF BACTERIOLOGY (2001)
Virulence genes in the pathogenic yeast Candida albicans
F Navarro-García et al.
FEMS MICROBIOLOGY REVIEWS (2001)
Practice guidelines for the treatment of candidiasis
JH Rex et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
